Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Axial Spondyloarthritis Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | Janssen Pharma, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharma, Galapago, Kyowa Kirin Co, Eli Lilly
4+ mon, 1+ week ago (611+ words) Some of the key facts of the Axial Spondyloarthritis Market Report: The Axial Spondyloarthritis market size is anticipated to grow with a significant CAGR during the study period (2020-2034). In September 2024, UCB, a global biopharmaceutical company, announced that the U.S. Food and…...
Ensysce expands into neuroplastogenic pain with USD 77m Cy Biopharma acquisition
1+ mon, 1+ week ago (121+ words) San Diego-based Ensysce Biosciences (Nasdaq: ENSC) has acquired Cy Biopharma and secured up to USD 77...
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma
3+ week, 6+ day ago (85+ words) New Castle News...Dunbar Pharma Plant-Based WaterClear THC⢠ATHLONE, Ireland--(BUSINESS WIRE)--Aug 18, 2026-- Javascript...
Zealand Pharma launches new trial targeting psoriasis
1+ mon, 1+ day ago (124+ words) medwatch.com Zealand Pharma launches new trial...Pharmacokineticist, PK/PD Modelling & Simulation Student Assistant in Medical Affairs Laboratoriechef Pharma..., Kosmetik & Helse, Biofac/1948 Analyst agrees with Zealand Pharma sale of royalty rights Zealand Pharma...sells further royalty rights to Royalty Pharma…...
Cord Injury Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Kringle Pharma, Neuroplast, AbbVie, and Mitsubishi Tanabe Pharma America
7+ mon, 2+ week ago (666+ words) Spinal Cord Injury Companies: Kringle Pharma, Neuroplast, AbbVie, and Mitsubishi Tanabe Pharma America...
Tris Pharma Launches Adneuris Therapeutics to Advance a New Era in Pain Medicine
2+ mon, 5+ day ago (662+ words) markets.businessinsider.com...Tris Pharma Launches Adneuris Therapeutics to Advance a New Era in Pain Medicine MONMOUTH JUNCTION,...N.J., July 09, 2026 (GLOBE NEWSWIRE) -- Adneuris Therapeutics, a subsidiary of Tris Pharma, launched...The launch marks the next phase of Tris Pharma's growth strategy.......
Texas secures $286M as $7.4B Purdue Pharma opioid settlement takes effect
4+ mon, 1+ week ago (507+ words) The Fresno Bee/Tribune News Service via Get AUSTIN, Texas - A $7.4 billion settlement with Purdue Pharma...Texas marks this as a major step in efforts to hold the Purdue Pharma company accountable for its role...Purdue Pharma, the maker of…...
Vermont plays big part in $5 billion fine for Purdue Pharma
4+ mon, 2+ week ago (705+ words) by Mike Donoghue, Vermont News First, Vermont Business Magazine Opioid manufacturer Purdue Pharma LP...“Purdue Pharma put profits over patient health and safety,” Acting Attorney General Todd Blanche said...
OxyContin maker Purdue Pharma's settlement, by the numbers
4+ mon, 1+ week ago (247+ words) Purdue Pharma building in Stamford, Conn....OxyContin maker Purdue Pharma is set to dissolve and be replaced with a new company operating in the...
Tris Pharma debuts Adneuris Therapeutics in new approach to pain management
2+ mon, 5+ day ago (170+ words) Tris Pharma launched Adneuris Therapeutics on July 9 to advance a vision for pain medicine through the...“For more than two decades, Tris Pharma has built its reputation by challenging convention and advancing...address significant unmet needs,” said Jim Potenziano, chief…...